1. GBp

    3,782

    Today's change

    23.00 / +0.61%

    1 year change

    +14.68%

    As of Apr 17 2014 16:36 BST. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. April 17, 2014

    UK cancer charity and companies test new style of drug trial

    A partnership between drug companies and the charity Cancer Research UK is pioneering an approach to clinical development,...

  2. April 1, 2014

    Drugmakers learn to blend commerce with philanthropy in Africa

    Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Innovation in Healthcare

    Eliminating old ways of working and providing incentives for new ones to be adopted is...
Search more Special Reports on this topic.

  1. March 13, 2014

    AstraZeneca slips as drug hopes knocked

    AstraZeneca investors have been waiting six years for its MedImmune purchase to come good. According to JPMorgan Cazenove,...

  2. March 12, 2014

    Aerospace and automotive are UK manufacturing’s star performers

    Britain’s manufacturers are using cutting-edge technology and gadgets to improve products and processes as the sector...

  3. March 12, 2014

    Osborne ‘fights hard’ to keep science jobs after AstraZeneca deal

    George Osborne said he was “fighting hard” to keep science jobs in the northwest, after AstraZeneca struck a deal to sell...

  4. February 6, 2014

    Sanofi and AstraZeneca prove upbeat on range of new treatments

    AstraZeneca and Sanofi trumpeted progress towards a slew of new drugs for conditions ranging from arthritis to cancer on...

  5. February 6, 2014

    Pascal wagers AstraZeneca’s replenished pipeline will deliver

    Pascal Soriot has half-justified his £4m signing-on bonus from AstraZeneca. Shares in the drugs group have risen about 26...

  6. February 6, 2014

    Loss of drug patents delivers more pain to AstraZeneca

    AstraZeneca suffered more pain from the loss of drug patents in the fourth quarter but Pascal Soriot, chief executive,...

  7. February 5, 2014

    Cash and strong pipeline give GSK a shot in the arm

    “Medicine can only cure curable disease, and then not always,” so the Chinese proverb goes. Fortunately for GlaxoSmithKline,...

  8. January 14, 2014

    Fund managers lead stock indices lower

    After several days in neutral, Europe’s main equities markets have changed gear – but into reverse. There are broad losses...

  9. January 8, 2014

    AstraZeneca strikes deal with UK’s Immunocore

    AstraZeneca has struck a deal with a fast-growing UK biotech company to develop treatments that use the body’s immune system...

  10. December 29, 2013

    Chris Finlayson, the BG Group chief seeking to fill big shoes

    Chris Finlayson was not long into his new job as chief executive of BG Group when he sold the company plane. The FTSE 100...

  11. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

  12. December 26, 2013

    Drug groups pin hopes on Iran market potential

    When Pfizer sold a small batch of medicines to Iran last year, the process was painful. The pharmaceutical group needed...

  13. December 20, 2013

    Week in Review, December 20

    A round-up of some of the week’s corporate events and news stories. Saab lands key Brazil fighter contract In a surprise...

  14. December 19, 2013

    AstraZeneca: Astra-nomical

    AstraZeneca has hired the über-cool architects Herzog & de Meuron to design its headquarters and research centre in...

  15. FT Alphaville

    December 19, 2013

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE Izzy continues to expand her theory of money entanglement, a look at the relationship...

  16. December 19, 2013

    AstraZeneca in $4bn buyout of diabetes venture partner

    AstraZeneca is to buy out its joint venture with Bristol-Myers Squibb in a deal worth up to $4.3bn, as it seeks to...

  17. December 17, 2013

    GSK steps up response to concerns over marketing

    GSK’s decision this week to stop paying speakers’ fees and travel expenses for doctors attending medical conferences by 2015...

  18. December 15, 2013

    Alert over Europe’s struggle to compete

    Europe’s 50 top industrialists are sounding the alarm about Europe’s gap in competitiveness to US and Asian rivals,...

  19. December 10, 2013

    More must be done to put ideas into practice

    It is more than two years since AstraZeneca launched a medicine for people with heart problems. In the UK, the authorities...

  20. December 3, 2013

    AstraZeneca bid speculation centres on Forest

    What might AstraZeneca buy? The question has been constant ever since chief executive Pascal Soriot last year cancelled the...

  21. FT Alphaville

    December 3, 2013

    AstraZeneca said to eye Forest Labs bid

    What’s been lighting a fire under Forest Laboratories? The developer of antidepressants and Alzheimer’s treatments hit a...

  22. November 21, 2013

    AstraZeneca climbs despite Citi’s caution

    Buy AstraZeneca, said Citigroup. But not yet. AstraZeneca rose 2.8 per cent to £34.01 after Citi told clients that consensus...

  23. November 19, 2013

    UK life sciences get shot in the arm

    In an empty field on the southern outskirts of Cambridge, Pascal Soriot is overseeing investment in an ambitious new complex...

  24. November 19, 2013

    AstraZeneca appoints Tate architects to design Cambridge HQ

    AstraZeneca has turned to art in its search for better science, announcing on Tuesday that the architect behind London’s...

  25. November 11, 2013

    AstraZeneca to invest £120m in UK factory

    AstraZeneca is to invest £120m in a new factory in Macclesfield in the northwest of England, in the latest example of a...

  26. November 8, 2013

    Bristol-Myers Squibb could realise $6bn from diabetes franchise

    Bristol-Myers Squibb could generate up to $6bn from the sale of its diabetes franchise, according to an analyst’s projection...

  27. November 3, 2013

    US regulators probe AstraZeneca drug test

    When US regulators re-examined data used to approve a medicine launched by AstraZeneca two years ago, they found at least...

  28. October 31, 2013

    AstraZeneca names new CFO as profits slide

    AstraZeneca reported a sharp fall in third-quarter profits on the back of generic competition, as it named a former...

  29. October 28, 2013

    AstraZeneca bounces on shorts warning

    AstraZeneca, Europe’s least popular large-cap drugmaker among analysts, bounced on Monday after Merrill Lynch advised...

  30. October 15, 2013

    Woodford departure will hit Invesco hard

    “Neil Woodford leaving Invesco Perpetual is huge. It is even bigger than Anthony Bolton leaving Fidelity,” says the head of...

  31. October 15, 2013

    AstraZeneca experiments with Spirogen deal

    AstraZeneca, the Anglo-Swedish pharmaceutical group struggling to boost its pipeline of experimental medicines, is to pay at...

  32. September 30, 2013

    Europe belt tightening will hit pharma, warns Roche chief

    Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and...

  33. September 16, 2013

    South Korea probes Celltrion over insider trading

    South Korean regulators are investigating whether the chief executive of the country’s leading biopharmaceutical company...

  34. September 10, 2013

    GlaxoSmithKline under pressure over threat of US Advair generic

    GlaxoSmithKline’s shares came under pressure on Tuesday after US regulators issued draft guidelines raising the prospect of...

  35. September 2, 2013

    ‘Driverless’ buses on fast track to success in UK

    On bus route A from Cambridge rail station to Addenbrooke’s hospital, the driver sits with his hands on his knees as the...

  36. August 18, 2013

    Drug company contributions can ‘influence’ medical decisions

    Doctors in the US who are paid and entertained by drug companies are more than twice as likely to prescribe their products,...

  37. August 18, 2013

    Feike Sijbesma, chief of DSM

    For several months now, Feike Sijbesma has been doggedly promoting an idiosyncratic vision for transforming global...

  38. August 15, 2013

    FTSE 100 falls as investors turn cautious

    London equity markets remained lower on Thursday, even as UK retail sales rose at their fastest pace in two years in July....

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge

  2. Lex on whether Pearl Therapeutics deal will help AstraZeneca...
    June 10, 2013

    Lex on whether Pearl Therapeutics deal will help AstraZ...

  3. Lex on Pascal Soriot's strategy for coping with AstraZeneca's...
    March 21, 2013

    Lex on Pascal Soriot's strategy for coping with AstraZe...